Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-institutional Evaluation of the Cost-effectiveness of PSMA-PET/CT for the Detection of Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients

NCT05000827 is registered in ClinicalTrials.gov with Canisius-Wilhelmina Hospital as lead sponsor.

NCT NCT05000827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05000827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-institutional Evaluation of the Cost-effectiveness of PSMA-PET/CT for the Detection of Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients
Lead sponsor
Canisius-Wilhelmina Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
July 28, 2021
Completion date
August 31, 2026
Enrollment
706 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastases, prostate cancer, prostate cancer metastatic